Search
for
Sort by
Research 30 of 756
- Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- The latest options and future agents for treating male hypogonadism
- Detection of Male Hypogonadism in Patients with Post COVID-19 Condition
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- Androgen Treatment in Adolescent Males With Hypogonadism
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Nanomilled Oral Testosterone Plus Dutasteride Effectively Normalizes Serum Testosterone in Normal Men With Induced Hypogonadism
- Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 9 Days in Normal Men With Experimental Hypogonadism
- Pharmacokinetics of 2 Novel Formulations of Modified-Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental Hypogonadism
- Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
- Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
- Serum testosterone levels and clinical signs of hypogonadism in men with type 2 diabetes
- Re: Clomiphene Citrate and Human Chorionic Gonadotropin are Both Effective in Restoring Testosterone in Hypogonadism: A Short-Course Randomized Study
- 423 Short-Acting Intramuscular Testosterone Delivered in the Clinic Setting Remains a Key Patient-Friendly and Patient-Directed Option in the Contemporary Management of Hypogonadism
- Pharmacokinetics of Modified Slow-Release Oral Testosterone over 10 Days in Normal Men with Experimental Hypogonadism
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- Sex Steroids, Precursors, and Metabolite Deficiencies in Men With Isolated Hypogonadotropic Hypogonadism and Panhypopituitarism: A GCMS-Based Comparative Study
- Idiopathic hypogonadotropic hypogonadism in a male runner is reversed by clomiphene citrate
- The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
- [Dermatologic aspects of male hypogonadism].
- Development of prostate cancer in a patient with primary hypogonadism: intratumoural steroidogenesis in prostate cancer tissues
- Cerebellar hypoplasia, hypergonadotrophic hypogonadism, retinitis pigmentosa, alopecia, microcephaly, psychomotor retardation, and short stature: “D-CHRAMPS syndrome”
- The effect of chemotherapy regimens in male germ cell tumors on the development of primary hypogonadism
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Emerging medication for the treatment of male hypogonadism
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Emerging drugs for hypogonadism